Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11378 | 919 | 35.5 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
390 | 16316 | MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ASSOC CARDIAC | Address | 8 | 100% | 1% | 5 |
2 | ASSOC RIC CARDIOL | Address | 3 | 60% | 0% | 3 |
3 | CLIN EXPT MED 2 | Address | 3 | 60% | 0% | 3 |
4 | LOW CHOLESTEROL | Author keyword | 2 | 26% | 1% | 5 |
5 | ETOFYLLIN CLOFIBRATE | Author keyword | 1 | 100% | 0% | 2 |
6 | HEART DISEASE OF UNCERTAIN ETIOLOGY | Author keyword | 1 | 100% | 0% | 2 |
7 | PROSPECTIVE STUDY LONG TERM | Author keyword | 1 | 100% | 0% | 2 |
8 | NUTR CONSUMER SAFETY | Address | 1 | 22% | 0% | 4 |
9 | TOTAL SERUM CHOLESTEROL | Author keyword | 1 | 23% | 0% | 3 |
10 | SEVEN COUNTRIES STUDY | Author keyword | 1 | 17% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPOCHOLESTEROLEMIA | 13 | 28% | 4% | 40 |
2 | LOW BLOOD CHOLESTEROL | 7 | 33% | 2% | 18 |
3 | NON CARDIOVASCULAR DISEASE | 6 | 100% | 0% | 4 |
4 | SERBIAN COHORTS | 6 | 100% | 0% | 4 |
5 | 7 COUNTRIES | 5 | 12% | 4% | 37 |
6 | TOTAL SERUM CHOLESTEROL | 3 | 22% | 1% | 13 |
7 | EUROPEAN COHORTS | 3 | 45% | 1% | 5 |
8 | PAISLEY SURVEY | 3 | 60% | 0% | 3 |
9 | SERUM TOTAL CHOLESTEROL | 2 | 12% | 2% | 18 |
10 | ITALIAN RURAL AREAS | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds | 2010 | 40 | 33 | 48% |
REPORT OF THE CONFERENCE ON LOW BLOOD CHOLESTEROL - MORTALITY ASSOCIATIONS | 1992 | 515 | 64 | 39% |
The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review | 2014 | 5 | 78 | 31% |
Atypical plasma lipid profile in cancer patients: Cause or consequence? | 2014 | 2 | 100 | 43% |
Cross sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: The Honolulu Heart Program | 1997 | 35 | 18 | 72% |
SERUM-CHOLESTEROL AND CANCER RISK - AN EPIDEMIOLOGIC PERSPECTIVE | 1992 | 74 | 78 | 74% |
Low cholesterol and cancer | 1996 | 13 | 42 | 48% |
CHOLESTEROL REDUCTION AND LIFE EXPECTANCY - A MODEL INCORPORATING MULTIPLE RISK-FACTORS | 1987 | 160 | 33 | 30% |
Lipoprotein alterations and atherosclerosis in the elderly | 1997 | 22 | 29 | 41% |
EFFECTS OF CORONARY RISK REDUCTION ON THE PATTERN OF MORTALITY | 1990 | 24 | 3 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ASSOC CARDIAC | 8 | 100% | 0.5% | 5 |
2 | ASSOC RIC CARDIOL | 3 | 60% | 0.3% | 3 |
3 | CLIN EXPT MED 2 | 3 | 60% | 0.3% | 3 |
4 | NUTR CONSUMER SAFETY | 1 | 22% | 0.4% | 4 |
5 | SRI DEVARAJ URS MED | 1 | 21% | 0.3% | 3 |
6 | CARDIOVASC P NEPHROL ANESTHESIOL GERIAT | 1 | 11% | 0.7% | 6 |
7 | DAVID GEFFEN MEDCEDARS SINAI MED | 1 | 50% | 0.1% | 1 |
8 | DIPARTIMENTO SCI CHIRURG TR IANTO ORGANO | 1 | 50% | 0.1% | 1 |
9 | EQUIPE ECREINCLARACRNH AUVERGNEINRAUMR 1019 | 1 | 50% | 0.1% | 1 |
10 | GLOSTRUP HOSP MED INTERNAL MED C | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000172446 | LOW DENSITY LIPOPROTEIN LDL RECEPTORS//ATHEROGENIC MICE//BIOCHEM BIOPHYS S |
2 | 0.0000147164 | HLTH FAMILY STUDIES//FDN JIMENEZ DIAZ UNIV HOSP//FORENSIC PATIENT |
3 | 0.0000108617 | MICROPOPULATION//MICROPOPULATION MODEL//EXPONENTIAL RISK AVOIDANCE MODELS |
4 | 0.0000104845 | LOVASTATIN//BB BIOCYT//PEDIAT PNEUMONOL ALLERG DIS HEMATOL |
5 | 0.0000101720 | APOLIPOPROTEIN B EXPRESSION//ENDOTOXIN NEUTRALIZATION//MOL MECH INFECT |
6 | 0.0000093003 | HLTH PROMOT HLTH CARE 1//NUTR LIFESTYLE//HEART INTERNAL MED |
7 | 0.0000091106 | STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN |
8 | 0.0000089291 | REFLOTRON//DESK TOP ANALYZERS//MEMBRANE STRIP |
9 | 0.0000087453 | 12 HYDROXY EICOSATETRAENOIC ACID//CORRELATES OF DEATH//GLOMERULAR FILTRATION RATE EGFR |
10 | 0.0000065153 | COGNITIVE FUNCTION IN ELDERLY//HS BISPEBJERG//HOSPITAL MEALS |